nach oben

Rheumatology International

Erschienen in:

01.06.2009 | Review Article

The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications

verfasst von: Sophie P. Toya, George E. Tzelepis

Erschienen in: Rheumatology International | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Scleroderma sine scleroderma (ssSSc) is an occult form of systemic sclerosis that may cause diagnostic difficulties due to the absence of skin involvement. Delays in the diagnosis of ssSSc means lost opportunites to address and treat the often lethal involvement of internal organs such as the lungs and heart. In this systemic review we collected all published cases of ssSSc using EMBASE, MEDLINE, PubMed, and Web of Science from 1950 to present. Our purpose was to describe the range and frequency of the clinical manifestations of ssSSc. A total of 108 published cases of ssSSc were analyzed. Lung involvement was present in 66% of cases. Peripheral vascular system involvement was present in all patients whereas gastrointestinal manifestations were present in 82% of the cases. Overall the clinical presentation is subtle and heightened clinical awareness is required to facilitate prompt recognition and treatment.

Abrams HL, Carnes WH, Eaton J (1954) Alimentary tract in disseminated scleroderma with emphasis on small bowel. Arch Intern Med 94:61–81

Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 43:444–451. doi:10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G PubMedCrossRef

Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Moinzadeh P, Muller-Ladner U et al (2008) The registry of the German network for systemic scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology 47:1185–1192. doi:10.1093/rheumatology/ken179 PubMedCrossRef

Inachi S, Mizutani H, Ando Y, Shimizu M (1996) Progressive systemic sclerosis sine scleroderma which developed after exposure to epoxy resin polymerization. J Dermatol 23:344–346PubMed

Sanders PW, Herrera GA, Ball GV (1988) Acute renal failure without fibrotic skin changes in progressive systemic sclerosis. Nephron 48:121–125. doi:10.1159/000132604 PubMedCrossRef

Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M (2004) ANCA-related crescentic glomerulonephritis in a patient without marked dermatological change and malignant hypertension. Intern Med 43:496–502. doi:10.2169/internalmedicine.43.496 PubMedCrossRef

Ferri C, Bernini L, Gremignai G, Latorraca A, Fazzi P, Tavon A, Solfanelli S, Bombardieri S (1992) Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange. Int J Artif Organs 15:426–431PubMed

Park YW, Woo H, Joon HJ, Park HW, Cho JG, Shin SS, Lee SS (2007) Systemic sclerosis sine scleroderma associated with Wolff-Parkinson-White syndrome. Scand J Rheumatol 36:68–70. doi:10.1080/03009740600759894 PubMedCrossRef

Sanchis DV, Garcia GA, Yglesias PJM (2006) Systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Clin Rheumatol 25:382–383. doi:10.1007/s10067-005-0026-z CrossRef

10.

Agard C, Hamidou M, Meriot M, Prendki V, Grolleau JY, Boutet-Madrange S (2002) Systemic sclerosis sine scleroderma revealed by pulmonary interstitial fibrosis. Rev Med Interne 23:1032–1034. doi:10.1016/S0248-8663(02)00732-4 PubMed

11.

Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK (2006) Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung. Dis Chest 130:976–981. doi:10.1378/chest.130.4.976 CrossRef

12.

Hayakawa I, Sato S, Hasegawa M, Echigo T, Takehara K (2004) A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension. Clin Rheumatol 23:266–268. doi:10.1007/s10067-004-0876-9 PubMedCrossRef

13.

Kubo N, Sawayama Y, Okada K, Nakagawa Y, Asou Y, Nabeshima S, Otsuka T, Kashiwagi S, Hayashi J (2002) A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation. Ryumachi 42:676–681PubMed

14.

Kudoh K, Shibata C, Funayama Y, Fukushima K, Takahashi K, Ogawa H, Sagami Y, Hirabayashi Y, Moriya T, Sasaki I (2007) Gastrojejunostomy and duodenojejunostomy for megaduodenum in systemic sclerosis sine scleroderma: report of a case. Dig Dis Sci 52:2257–2260. doi:10.1007/s10620-006-9195-0 PubMedCrossRef

15.

Oiwa H, Ikemoto Y, Mandai K, Koide K, Nishida T, Tabe Y (2005) A case of systemic sclerosis sine scleroderma associated with perforation of an afferent loop after subtotal gastrectomy with Billroth 2 anastomosis for its severe gastrointestinal involvement. Mod Rheumatol 15:371–373. doi:10.1007/s10165-005-0422-x PubMedCrossRef

16.

Rodnan GP, Fennel RH (1962) Progressive systemic sclerosis sine scleroderma. JAMA 180:665–670PubMed

17.

Horn HC, Ottosen P, Junker P (2001) Renal crisis in asclerodermic scleroderma-lupus overlap syndrome. Lupus 10:886–888. doi:10.1191/096120301701548382 PubMedCrossRef

18.

Cubo Romano P, Minguez Garcia P, Munoz Albarran S, Abad Cardiel M, Pontes Navarro JC (2005) Interstitial pneumonitis as a clinical manifestation in a patient with systemic sclerosis without scleroderma. Med Interna 22:402–403

19.

De Villiers WJ, Jordaan HF, Bates W (1992) Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis. Clin Exp Dermatol 17:127–131. doi:10.1111/j.1365-2230.1992.tb00180.x PubMedCrossRef

20.

Gala B, Kanagarajan K, Rupanagudi V, Dhar S, Doshi R, Krishnan P (2004) Interstitial lung disease (ILD) as a sole manifestation of visceral involvement in systemic sclerosis sine scleroderma (SSSSC). Chest 126(Suppl 4):993–994. doi:10.1378/chest.126.3.993

21.

Alturkmani R, Kadaria D, Ali M, Koirala K, Freire AX, Muthiah MP (2008) Systemic sclerosis sine scleroderma presenting as non specific interstitial pneumonia (NSIP). J Invest Med 56(Suppl):412–413

22.

Slobodin G, Rosner I, Rozenbaum M, Naschitz JE, Zuckerman E, Yeshurun D (2002) Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion. Rheumatol Int 22:170–172. doi:10.1007/s00296-002-0222-y PubMedCrossRef

23.

Miller RD, Fowler WS, Helmholz FH Jr (1959) Scleroderma of the lungs. Proc Staff Meet Mayo Clin 34:66–75PubMed

24.

Crown S (1961) Visceral scleroderma without skin involvement. BMJ 2:1541–1543PubMedCrossRef

25.

Travis WD, King TE Jr, Bateman ED, Lynch DA, Capron F, Center D (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304

26.

Fischer A, Swigris JJ, Groshong SD, Cool CD, Sahin H, Lynch DA, Curran-Everett D, Gillis JZ, Meehan RT, Brown KK (2008) Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 134:601–605. doi:10.1378/chest.08-0053 PubMedCrossRef

27.

Pauling JD, Gunawardena H, Coghlan JG, Easaw J, Suntharalingam J, Mchugh NJ (2008) Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma. Rheumatology 47:1431–1432. doi:10.1093/rheumatology/ken241 PubMedCrossRef

28.

Fischer A, Misumi S, Curran-Everett D, Meehan RT, Ulrich SK, Swigris JJ, Frankel SK, Cosgrove GP, Lynch DA, Brown KK (2007) Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease. Chest 131:988–992. doi:10.1378/chest.06-2317 PubMedCrossRef

29.

Phan TG, Cass A, Gillin A, Trew P, Fertig N, Sturgess A (1999) Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma. J Rheumatol 26:2489–2492PubMed

30.

Plastiras SC, Kelekis N, Tzelepis GE (2006) Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 354:2194–2196. doi:10.1056/NEJMc053128 PubMedCrossRef

31.

Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, Gialafos EJ, Moyssakis I, Moutsopoulos HM (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56:3827–3836. doi:10.1002/art.22971 PubMedCrossRef

32.

Horswell RR, Hargrove MD Jr, Peete WP (1960) Scleroderma presenting as the malabsorption syndrome. Gastroenterology 40:580–582

33.

Navon P, Halevi A, Brand A, Branski D, Rubinow A (1993) Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud’s phenomenon. Acta Paediatr 82:122–123. doi:10.1111/j.1651-2227.1993.tb12539.x PubMedCrossRef

34.

Katrib A, Sturgess A, Bertouch JV (1999) Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19:61–63. doi:10.1007/s002960050102 PubMedCrossRef

35.

Canet JJ, Castane J, Alvarez M, Nava JM, Llibre J (2002) Scleroderma renal crisis sine scleroderma. Nephron 90:119–120. doi:10.1159/000046327 PubMedCrossRef

36.

Molina JF, Anaya JM, Cabrera GE, Hoffman E, Espinoza LR (1995) Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis. J Rheumatol 22:557–560PubMed

37.

Zwettler U, Andrassy K, Waldherr R, Ritz E (1993) Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis 22:53–56PubMed

38.

Stanghellini V (1999) Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol 231:20–28. doi:10.1080/003655299750025237 CrossRef

39.

Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA (2006) Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 129:794–800. doi:10.1378/chest.129.3.794 PubMedCrossRef

40.

Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176:691–697. doi:10.1164/rccm.200702-220OC PubMedCrossRef

41.

Tzelepis GE, Toya SP, Moutsopoulos HM (2008) Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 31:11–20. doi:10.1183/09031936.00060107 PubMedCrossRef

42.

Jolly M, Smaron M, Utset TO, Ellman M (2003) Are isolated antinucleolar antibodies a marker of Scleroderma? J Clin Rheumatol 9:291–295. doi:10.1097/01.rhu.0000089790.80026.f4 PubMedCrossRef

43.

Cottin V, Lega JC, Fabien N, Cordier JF (2007) When to stop in the quest of formes frustes of connective tissue disease? Clin Rheumatol 26:615–616. doi:10.1007/s10067-007-0536-y PubMedCrossRef

44.

Harvey G, Black C, Maddison P, McHugh N (1997) Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. J Rheumatol 24:477–484PubMed

45.

Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600. doi:10.1001/archinte.158.6.595 PubMedCrossRef

46.

Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M (2007) Office capillaroscopy in systemic sclerosis. Clin Rheumatol 26:1268–1274. doi:10.1007/s10067-006-0489-6 PubMedCrossRef

47.

Kraus A, Alarcon-Segovia D (1991) Air esophagogram and intestinal pseudoocclusion in a patient with scleroderma. J Rheumatol 18:897–899PubMed

48.

Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M (2002) The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 19:121–127PubMed

Titel: The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications
verfasst von: Sophie P. Toya
George E. Tzelepis
Publikationsdatum: 01.06.2009
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 8/2009
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-0878-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2009

Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis

Results of arthroscopic adhesiolysis and manipulation in the stiff knee secondary to septic arthritis and inflammatory arthritis

The ubiquitin–proteasome pathway and viral infections in articular cartilage of patients with osteoarthritis

Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease

Pulse electromagnetic fields effects on serum E2 levels, chondrocyte apoptosis, and matrix metalloproteinase-13 expression in ovariectomized rats